Rishi Laser reported a 72% year-on-year drop in net profit to Rs 0.50 crore for Q1 FY27, despite a 3% rise in revenue. Higher operational costs, especially employee benefits, impacted profitability. The company also completed a warrant conversion, raising capital for expansion.
Rishi Laser Q1 FY27 Results: Profit Dips 72% Amid Rising Costs
Net profit for the quarter ended June 30, 2026 (Q1 FY27) stood at Rs 0.50 crore (Rs 49.54 lakh). Revenue from operations increased by 3% to Rs 42.26 crore (Rs 4225.88 lakh). Reader Takeaway: Revenue up, but higher costs hit profit; warrant conversion boosts capital. ## What just happened Rishi Laser Limited announced its financial results for the first quarter ended June 30, 2026 (Q1 FY27). The company reported a revenue from operations of Rs 42.26 crore, a slight increase from Rs 41.03 crore in the same quarter last year. However, net profit after tax (PAT) saw a significant decline of 72%, falling to Rs 0.50 crore from Rs 1.77 crore in the corresponding period of the previous fiscal year. Total expenses rose to Rs 41.83 crore from Rs 38.78 crore, largely due to an increase in employee benefit expenses, which went up to Rs 9.26 crore from Rs 6.88 crore year-on-year. ## Why this matters The decline in profitability, despite revenue growth, signals pressure on the company's margins. Investors will closely watch how Rishi Laser manages its increasing operational costs, particularly employee expenses, which are impacting the bottom line. The successful conversion of warrants, however, has infused capital that is earmarked for expansion, a key driver for future growth. ## The backstory Rishi Laser Limited is involved in the manufacturing of laser-based products. The company operates in a competitive environment, and managing operational efficiencies is crucial for sustained profitability. The current results reflect a challenging quarter where cost management became a key concern. ## What changes now The company has successfully converted 8,00,000 warrants into equity shares, allotting them at Rs 150 each. This infusion of capital, totaling Rs 12 crore, will support capital expansion and general corporate purposes. The Board has also scheduled its 34th Annual General Meeting for September 25, 2026. ## Risks to watch Key risks include the continued rise in operational expenses, which could further erode profit margins. Dependency on a few key products or clients could also pose a risk. Management's ability to effectively deploy the newly raised capital for expansion and achieve projected growth will be critical. ## Context metrics (time-bound) - Q1 FY27 Revenue: Rs 42.26 crore (vs Rs 41.03 crore in Q1 FY26) - Q1 FY27 PAT: Rs 0.50 crore (vs Rs 1.77 crore in Q1 FY26) - Employee Benefit Expenses: Rs 9.26 crore (vs Rs 6.88 crore in Q1 FY26) - Warrant Conversion: 8,00,000 shares at Rs 150 each. ## What to track next Investors should monitor the company's performance in the upcoming quarters, focusing on its ability to control costs, drive sales growth, and effectively utilize the capital raised from warrant conversion for expansion projects. The outcome of the upcoming AGM might also provide insights into future strategic directions.
